Among women living at least 1 year after being diagnosed with breast cancer, aspirin use decreases the likelihood that those women will die from breast cancer or that their cancer will recur, according to a new study.
Among women living at least 1 year after being diagnosed with breast cancer, aspirin use (anywhere from 1 to 7 days per week) decreases the likelihood that those women will die from breast cancer or that their cancer will recur, according to the results of a prospective observational study.
The study reported responses from 4,164 female registered nurses participating in the Nurses' Health Study who were diagnosed with stage I, II, or III breast cancer between 1976 and 2002. The researchers observed the women until their death or until June 2006, whichever came first. Among other things, the nurses were asked whether they took aspirin 0, 1, 2 to 5, or 6 to 7 days per week.
In terms of breast cancer deaths, adjusted relative risks (RR) for 1, 2 to 5, and 6 to 7 days of aspirin use per week compared with no use were 1.07 (95% CI, 0.70-1.63), 0.29 (95% CI, 0.16-0.52), and 0.36 (95% CI, 0.24-0.54), respectively (test for linear trend, P<.001).
The associations did not differ appreciably by cancer stage, menopausal status, body mass index, or estrogen receptor status.
Holmes MD, Chen WY, Li L, Hertzmark E, Spiegelman D,Hankinson SE. Aspirin intake and survival after breast cancer. J Clin Oncol. 2010;28(9):1467-1472.
Unraveling preeclampsia: Insights into heterogeneity and intravascular inflammation
April 22nd 2024A recent study delved into the intricate clusters of term preeclampsia, shedding light on its diverse manifestations and the pivotal role of intravascular inflammation, paving the way for improved classification and management strategies.
Read More
Personalized opioid protocol for cesarean deliveries: Reduced prescriptions reported
April 19th 2024A recent suggests that implementing a personalized opioid prescription protocol significantly reduces total morphine milligram equivalents and the number of opioid tablets prescribed at discharge following cesarean delivery.
Read More
Long-term mortality risks for women with adverse pregnancy outcomes
April 19th 2024A recent study revealed that women who experience major adverse pregnancy outcomes face heightened long-term mortality risks, shedding light on the need for comprehensive understanding and preventative measures in women's health.
Read More